Home › NDC Lookup › RxCUI directory › RxCUI 2173841

Solriamfetol 150 MG Oral Tablet [Sunosi] — RxCUI 2173841

RxNorm drug concept · Semantic branded drug
RxCUI 2173841 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2173841
Official nameSolriamfetol 150 MG Oral Tablet [Sunosi]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSunosi 150 MG Oral Tablet; solriamfetol 150 MG (equivalent to solriamfetol HCl 178.5 MG) Oral Tablet [Sunosi]
FDA products mapped2
Package NDCs mapped6
Reported Medicaid activity (SDUD)15,014 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Solriamfetol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sunosi is designed to reduce the excessive sleepiness that comes with narcolepsy or sleep apnea — it helps you feel more awake and alert during the day. It's not a stimulant meant...
  • What exactly does Sunosi do — will it keep me awake all day?
  • No — Sunosi does not treat the blocked airway that causes obstructive sleep apnea. It only helps with the daytime sleepiness that results from it. Your CPAP or other OSA treatment...
  • Can I stop using my CPAP machine once I start Sunosi?
📖 Read our full Solriamfetol guide →

🕸️ Concept Web — How Solriamfetol 150 MG Oral Tablet [Sunosi] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Solriamfetol 150 MG Oral Tablet [Sunosi] RxCUI 2173841

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Solriamfetol 2121751
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sunosi 2121759
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Solriamfetol Oral Tablet 2121755
    • Solriamfetol Oral Product 2121753
    • Solriamfetol Pill 2121754
    • Solriamfetol Oral Tablet [Sunosi] 2121761
    • Sunosi Oral Product 2121762
    • Sunosi Pill 2121763
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Solriamfetol 150 MG Oral Tablet SCD · 2121758
  • Solriamfetol 150 MG SCDC · 2121757
  • Solriamfetol Oral Tablet SCDF · 2121755
  • Solriamfetol Oral Product SCDG · 2121753
  • Solriamfetol Pill SCDG · 2121754

Brand-Name Concepts

  • Solriamfetol 150 MG [Sunosi] SBDC · 2173840
  • Solriamfetol Oral Tablet [Sunosi] SBDF · 2121761
  • Sunosi Oral Product SBDG · 2121762
  • Sunosi Pill SBDG · 2121763
  • Sunosi BN · 2121759

📦 FDA Products & Package NDCs

2 products · 6 package NDCs
6 package NDCs map to RxCUI 2173841 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
81968-0350-01 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (81968-350-01) SUNOSI Axsome Therapeutics, Inc. 2022-06-02
81968-0350-07 7 TABLET, FILM COATED in 1 BLISTER PACK (81968-350-07) SUNOSI Axsome Therapeutics, Inc. 2022-06-02
81968-0350-10 10 BLISTER PACK in 1 CARTON (81968-350-10) / 7 TABLET, FILM... SUNOSI Axsome Therapeutics, Inc. 2022-06-02
81968-0351-01 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (81968-351-01) SUNOSI Axsome Therapeutics, Inc. 2022-06-02
81968-0351-07 7 TABLET, FILM COATED in 1 BLISTER PACK (81968-351-07) SUNOSI Axsome Therapeutics, Inc. 2022-06-02
81968-0351-10 10 BLISTER PACK in 1 CARTON (81968-351-10) / 7 TABLET, FILM... SUNOSI Axsome Therapeutics, Inc. 2022-06-02
Observed labelers: Axsome Therapeutics, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.